Antioxidative treatment retards progression of idiopathic membranous nephropathy.
Braun
N
N
Frank
J
J
Biesalski
H K
HK
Risler
T
T
D000111:Acetylcysteine / Q000627:therapeutic use; D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D015938:Complement Membrane Attack Complex / Q000032:analysis / Q000652:urine; D018450:Disease Progression; D015433:Glomerulonephritis, Membranous / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000473:pathology; D008297:Male; D012643:Selenium / Q000627:therapeutic use; D017392:Thiobarbituric Acid Reactive Substances / Q000032:analysis; D013997:Time Factors; D014810:Vitamin E / Q000097:blood / Q000627:therapeutic use; D019207:beta Carotene / Q000097:blood / Q000627:therapeutic use
D000975:Antioxidants; D015938:Complement Membrane Attack Complex; D017392:Thiobarbituric Acid Reactive Substances; D019207:beta Carotene; D014810:Vitamin E; D012643:Selenium; D001205:Ascorbic Acid; D000111:Acetylcysteine